190 related articles for article (PubMed ID: 24454961)
1. RHPS4 G-quadruplex ligand induces anti-proliferative effects in brain tumor cells.
Lagah S; Tan IL; Radhakrishnan P; Hirst RA; Ward JH; O'Callaghan C; Smith SJ; Stevens MF; Grundy RG; Rahman R
PLoS One; 2014; 9(1):e86187. PubMed ID: 24454961
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
3. Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration.
Leonetti C; Amodei S; D'Angelo C; Rizzo A; Benassi B; Antonelli A; Elli R; Stevens MF; D'Incalci M; Zupi G; Biroccio A
Mol Pharmacol; 2004 Nov; 66(5):1138-46. PubMed ID: 15304549
[TBL] [Abstract][Full Text] [Related]
4. Naphthalene diimide-derivatives G-quadruplex ligands induce cell proliferation inhibition, mild telomeric dysfunction and cell cycle perturbation in U251MG glioma cells.
Muoio D; Berardinelli F; Leone S; Coluzzi E; di Masi A; Doria F; Freccero M; Sgura A; Folini M; Antoccia A
FEBS J; 2018 Oct; 285(20):3769-3785. PubMed ID: 30095224
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes.
Gowan SM; Heald R; Stevens MF; Kelland LR
Mol Pharmacol; 2001 Nov; 60(5):981-8. PubMed ID: 11641426
[TBL] [Abstract][Full Text] [Related]
6. Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism.
Phatak P; Cookson JC; Dai F; Smith V; Gartenhaus RB; Stevens MF; Burger AM
Br J Cancer; 2007 Apr; 96(8):1223-33. PubMed ID: 17406367
[TBL] [Abstract][Full Text] [Related]
7. The G-quadruplex-stabilising agent RHPS4 induces telomeric dysfunction and enhances radiosensitivity in glioblastoma cells.
Berardinelli F; Siteni S; Tanzarella C; Stevens MF; Sgura A; Antoccia A
DNA Repair (Amst); 2015 Jan; 25():104-15. PubMed ID: 25467559
[TBL] [Abstract][Full Text] [Related]
8. G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells.
Berardinelli F; Tanori M; Muoio D; Buccarelli M; di Masi A; Leone S; Ricci-Vitiani L; Pallini R; Mancuso M; Antoccia A
J Exp Clin Cancer Res; 2019 Jul; 38(1):311. PubMed ID: 31311580
[TBL] [Abstract][Full Text] [Related]
9. G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells.
Amato R; Valenzuela M; Berardinelli F; Salvati E; Maresca C; Leone S; Antoccia A; Sgura A
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32183119
[TBL] [Abstract][Full Text] [Related]
10. Antitumor polycyclic acridines. 20. Search for DNA quadruplex binding selectivity in a series of 8,13-dimethylquino[4,3,2-kl]acridinium salts: telomere-targeted agents.
Cheng MK; Modi C; Cookson JC; Hutchinson I; Heald RA; McCarroll AJ; Missailidis S; Tanious F; Wilson WD; Mergny JL; Laughton CA; Stevens MF
J Med Chem; 2008 Feb; 51(4):963-75. PubMed ID: 18247546
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities.
Rizzo A; Iachettini S; Zizza P; Cingolani C; Porru M; Artuso S; Stevens M; Hummersone M; Biroccio A; Salvati E; Leonetti C
J Exp Clin Cancer Res; 2014 Oct; 33(1):81. PubMed ID: 25288403
[TBL] [Abstract][Full Text] [Related]
12. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect.
Salvati E; Leonetti C; Rizzo A; Scarsella M; Mottolese M; Galati R; Sperduti I; Stevens MF; D'Incalci M; Blasco M; Chiorino G; Bauwens S; Horard B; Gilson E; Stoppacciaro A; Zupi G; Biroccio A
J Clin Invest; 2007 Nov; 117(11):3236-47. PubMed ID: 17932567
[TBL] [Abstract][Full Text] [Related]
13. Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells.
Zhou G; Liu X; Li Y; Xu S; Ma C; Wu X; Cheng Y; Yu Z; Zhao G; Chen Y
Oncotarget; 2016 Mar; 7(12):14925-39. PubMed ID: 26908447
[TBL] [Abstract][Full Text] [Related]
14. Drug recognition and stabilisation of the parallel-stranded DNA quadruplex d(TTAGGGT)4 containing the human telomeric repeat.
Gavathiotis E; Heald RA; Stevens MF; Searle MS
J Mol Biol; 2003 Nov; 334(1):25-36. PubMed ID: 14596797
[TBL] [Abstract][Full Text] [Related]
15. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
[TBL] [Abstract][Full Text] [Related]
16. PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy.
Salvati E; Scarsella M; Porru M; Rizzo A; Iachettini S; Tentori L; Graziani G; D'Incalci M; Stevens MF; Orlandi A; Passeri D; Gilson E; Zupi G; Leonetti C; Biroccio A
Oncogene; 2010 Nov; 29(47):6280-93. PubMed ID: 20802516
[TBL] [Abstract][Full Text] [Related]
17. G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors.
Leonetti C; Scarsella M; Riggio G; Rizzo A; Salvati E; D'Incalci M; Staszewsky L; Frapolli R; Stevens MF; Stoppacciaro A; Mottolese M; Antoniani B; Gilson E; Zupi G; Biroccio A
Clin Cancer Res; 2008 Nov; 14(22):7284-91. PubMed ID: 19010844
[TBL] [Abstract][Full Text] [Related]
18. An integrative biological approach to the analysis of tissue culture data: application to the antitumour agent RHPS4.
Johnson LA; Byrne HM; Willis AE; Laughton CA
Integr Biol (Camb); 2011 Aug; 3(8):843-9. PubMed ID: 21773618
[TBL] [Abstract][Full Text] [Related]
19. Dimeric aryl-substituted imidazoles may inhibit ALT cancer by targeting the multimeric G-quadruplex in telomere.
Hu MH; Lin XT; Liu B; Tan JH
Eur J Med Chem; 2020 Jan; 186():111891. PubMed ID: 31759730
[TBL] [Abstract][Full Text] [Related]
20. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
